Citizens JMP Reiterates Market Outperform Rating on Cidara Therapeutics (CDTX)
Tweet Send to a Friend
Citizens JMP analyst Roy Buchanan reiterated a Market Outperform rating and $59.00 price target on Cidara Therapeutics (NASDAQ: CDTX)The analyst ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


